The T2D risk variant in HNF4A, rs18009617, was also able to activate gene expression similar to WT, whereas the MODY1 variant I271fs (that is known to exhibit loss-of-function [LOF])14 displayed loss of activity and was unable to upregulate target gene expression (Fig. 3c). This evidence concerns the gene HNF4A and type 2 diabetes mellitus.